The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment

AIM OF THE STUDY: To investigate the efficacy of evaluating prognosis and response to lung cancer treatment using M30 and M65 antigens, which are indicators of necrosis. MATERIAL AND METHODS: Forty-eightpatients with lung cancer, who were planned to receive neoadjuvant chemotherapy, and 38 healthy v...

Descripción completa

Detalles Bibliográficos
Autores principales: Coskun, Belkıs Nihan, Dizdar, Oguzhan Sıtkı, Korkmaz, Seniz, Ulukaya, Engin, Evrensel, Turkkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978762/
https://www.ncbi.nlm.nih.gov/pubmed/31992952
http://dx.doi.org/10.5114/wo.2019.91539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978762/
https://www.ncbi.nlm.nih.gov/pubmed/31992952
http://dx.doi.org/10.5114/wo.2019.91539

Ejemplares similares